Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)

被引:992
作者
Van den Steen, PE
Dubois, B
Nelissen, I
Rudd, PM
Dwek, RA
Opdenakker, G
机构
[1] Univ Louvain, Rega Inst Med Res, B-3000 Louvain, Belgium
[2] Univ Oxford, Glycobiol Inst, Oxford OX1 2JD, England
关键词
D O I
10.1080/10409230290771546
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The matrix metalloproteinases (MMPs) form an enzyme family of which gelatinase B (MMP-9) represents the largest and most complex member. We focus here on the biochemical properties, regulation, and functions of gelatinase B. The tight regulation of gelatinase B activity is highly complex and is established at five different levels. The transcription of the gelatinase B-gene depends on various cis-elements in its gene promotor and is induced or repressed by a large variety of soluble factors, including cytokines, growth factors, and hormones and by cellular contacts acting through specific signaling pathways. The specific regulation of its secretion occurs in cells storing gelatinase B in granules. After secretion, progelatinase B must be activated through an activation network. The enzyme activity is further regulated by inhibition and by other mechanisms, such as fine-tuning and stabilization by glycosylation. The ability of gelatinase B to degrade components of the extracellular matrix and to regulate the activity of a number of soluble proteins confers an important role in various physiological and pathological processes. These include reproduction, growth, development, inflammation, and vascular and proliferative diseases.
引用
收藏
页码:375 / 536
页数:162
相关论文
共 840 条
  • [21] Membrane type 1-matrix metalloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade
    Ara, T
    Deyama, Y
    Yoshimura, Y
    Higashino, F
    Shindoh, M
    Matsumoto, A
    Fukuda, H
    [J]. CANCER LETTERS, 2000, 157 (02) : 115 - 121
  • [22] Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia
    Asahi, M
    Wang, XY
    Mori, T
    Sumii, T
    Jung, JC
    Moskowitz, MA
    Fini, ME
    Lo, EH
    [J]. JOURNAL OF NEUROSCIENCE, 2001, 21 (19) : 7724 - 7732
  • [23] Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia
    Asahi, M
    Sumii, T
    Fini, ME
    Itohara, S
    Lo, EH
    [J]. NEUROREPORT, 2001, 12 (13) : 3003 - 3007
  • [24] Athayde N, 1999, J Matern Fetal Med, V8, P213
  • [25] Azuma M, 2000, ARTHRITIS RHEUM, V43, P1756, DOI 10.1002/1529-0131(200008)43:8<1756::AID-ANR12>3.0.CO
  • [26] 2-H
  • [27] BACKSTROM JR, 1995, J NEUROCHEM, V64, P1312
  • [28] Backstrom JR, 1996, J NEUROSCI, V16, P7910
  • [29] Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells
    Bafetti, LM
    Young, TN
    Itoh, Y
    Stack, MS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) : 143 - 149
  • [30] DISTRIBUTION OF THE MATRIX METALLOPROTEINASES STROMELYSIN, GELATINASE-A AND GELATINASE-B, AND COLLAGENASE IN CROHNS-DISEASE AND NORMAL INTESTINE
    BAILEY, CJ
    HEMBRY, RM
    ALEXANDER, A
    IRVING, MH
    GRANT, ME
    SHUTTLEWORTH, CA
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (02) : 113 - 116